Registered entities
ARVINAS, INC.
Reg. No. 463139663United States
Arvinas, Inc.
Reg. No. 001t000000WoJl3AAFUnited States
Innovation
26 patent families (12 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 2,788 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2016 | 7 |
| 2017 | 8 |
| 2018 | 21 |
| 2019 | 13 |
| 2020 | 9 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
Social engagement
Social engagement: 31K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
16 investors on record; lead investors include Nextech Invest, Canaan, 5AM Ventures, RA Capital Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 63% |
| Private equity | 4 | 25% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 1 | 6% |
Hiring activity
Hires periodically
5 roles tracked across 4 of the last 12 months
8 Feb 2026 · Summer Intern Neuroscience · New Haven
18 Jan 2026 · Associate Director, Clinical Development & Medical Affairs (CDMA) Operations & Innovation · New Haven
12 Jan 2026 · Co-op Biology-Oncology · New Haven
3 Nov 2025 · Manager, Accounting Operations · New Haven
Based on job postings tracked across public sources.
Recent activity
4 Jun 2026
Partnership
The Michael J. Fox Foundation for Parkinson's Research LITE and PPMI programs
1 Jun 2026
Event
American Society of Clinical Oncology (ASCO) annual meeting